BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$151M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$126M |
| 3 |
Alibaba
BABA
|
+$92.6M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$71M |
| 5 |
Lam Research
LRCX
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.15B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Apple
AAPL
|
+$837M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$723M |
| 5 |
Microsoft
MSFT
|
+$603M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.13% |
| 2 | Financials | 5.89% |
| 3 | Healthcare | 5.09% |
| 4 | Consumer Discretionary | 5% |
| 5 | Communication Services | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KEM
2526
DELISTED
KEMET Corporation
KEM
| $60.9K | ﹤0.01% |
3,472
-7,071
| -67% | -$132K |
|
|
NVO
2527
Novo Nordisk
NVO
$201B
| $60.8K | ﹤0.01% |
2,638
-92
| -3% | -$2.04K |
|
2528
First Industrial Realty Trust
FR
$8.33B
| $60.7K | ﹤0.01% |
2,102
-28,434
| -93% | -$880K |
|
2529
FormFactor
FORM
$10.3B
| $60.6K | ﹤0.01% |
4,304
+41
| +1% | +$572 |
|
2530
Clearwater Paper
CLW
$345M
| $60.6K | ﹤0.01% |
2,488
+1,492
| +150% | +$40.2K |
|
2531
SLM Corp
SLM
$5.27B
| $60.6K | ﹤0.01% |
7,294
-105,458
| -94% | -$1.05M |
|
2532
Vanguard Dividend Appreciation ETF
VIG
$114B
| $60.3K | ﹤0.01% |
616
+168
| +38% | +$17.5K |
|
|
BBT
2533
Beacon Financial Corp
BBT
$2.69B
| $60.3K | ﹤0.01% |
2,236
-1,428
| -39% | -$48K |
|
|
RVI
2534
DELISTED
Retail Value Inc. Common Shares
RVI
| $60.3K | ﹤0.01% |
25,656
-48,644
| -65% | -$128K |
|
2535
Azenta
AZTA
$1.46B
| $60.1K | ﹤0.01% |
2,294
-1,749
| -43% | -$51.1K |
|
|
ESPR
2536
DELISTED
Esperion Therapeutics
ESPR
| $59.8K | ﹤0.01% |
1,300
-373
| -22% | -$18K |
|
2537
Franklin Electric
FELE
$4.68B
| $59.6K | ﹤0.01% |
1,390
-1,400
| -50% | -$60.7K |
|
2538
Federal Agricultural Mortgage
AGM
$2.53B
| $59.6K | ﹤0.01% |
986
+156
| +19% | +$10.3K |
|
2539
Myriad Genetics
MYGN
$290M
| $59.2K | ﹤0.01% |
2,037
-2,937
| -59% | -$106K |
|
2540
Emcor
EME
$36.9B
| $59.2K | ﹤0.01% |
992
-5,923
| -86% | -$410K |
|
2541
Regenxbio
RGNX
$711M
| $59.2K | ﹤0.01% |
1,411
-649
| -32% | -$38.1K |
|
2542
Gray Television
GTN
$538M
| $59K | ﹤0.01% |
4,001
-1,311
| -25% | -$22.8K |
|
2543
Marriott Vacations Worldwide
VAC
$4.16B
| $58.8K | ﹤0.01% |
834
-3,994
| -83% | -$333K |
|
2544
CBIZ
CBZ
$2.96B
| $58.7K | ﹤0.01% |
2,979
+1,235
| +71% | +$26.4K |
|
|
LFC
2545
DELISTED
China Life Insurance Company Ltd.
LFC
| $58.5K | ﹤0.01% |
5,579
-5,051
| -48% | -$53.7K |
|
2546
Tidewater
TDW
$4.69B
| $58.4K | ﹤0.01% |
3,055
+2,272
| +290% | +$59.2K |
|
|
ATCO
2547
DELISTED
Atlas Corp.
ATCO
| $58.3K | ﹤0.01% |
7,445
+2,251
| +43% | +$19.6K |
|
2548
Olin
OLN
$2.18B
| $58.2K | ﹤0.01% |
2,893
-28,144
| -91% | -$600K |
|
|
BCPC
2549
Balchem Corp
BCPC
$5.69B
| $58.1K | ﹤0.01% |
741
-1,094
| -60% | -$98.8K |
|
2550
TFS Financial
TFSL
$4.95B
| $58.1K | ﹤0.01% |
3,599
-10,040
| -74% | -$154K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2018 Portfolio in Review
As of Q4 2018, BNP Paribas Financial Markets held 4,572 positions worth $42.3B, down 38% from $67.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets withdrew a net $18.9B in Q4 2018, closing 248 positions and reducing 2,296 holdings. Its most notable exit was Aetna Inc, an estimated $141M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.1% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in HUTCHMED worth $8.84M.
- BNP Paribas Financial Markets's largest Q4 2018 buy was HUTCHMED: 382,749 shares worth $8.84M.
- BNP Paribas Financial Markets added most to Celgene Corp in Q4 2018, an estimated $151M increase.
- BNP Paribas Financial Markets's biggest Q4 2018 reduction was Alphabet (Google) Class C, cutting an estimated $1.15B.
- BNP Paribas Financial Markets fully exited Aetna Inc in Q4 2018, selling an estimated $141M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $42.3B portfolio in Q4 2018.
- BNP Paribas Financial Markets opened 126 new positions and closed 248 in Q4 2018.
- BNP Paribas Financial Markets's portfolio value fell 38% quarter-over-quarter to $42.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2018, filed 12 Feb 2019.